Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model
- 31 October 2007
- journal article
- research article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 43 (4) , 517-522
- https://doi.org/10.1016/j.yjmcc.2007.06.003
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL52141)
This publication has 18 references indexed in Scilit:
- Epsilon protein kinase C as a potential therapeutic target for the ischemic heartCardiovascular Research, 2006
- Cardiac allograft vasculopathy: pathology, prevention and treatmentCurrent Opinion in Cardiology, 2006
- Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulatorsThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Suppression of Graft Coronary Artery Disease by a Brief Treatment With a Selective εPKC Activator and a δPKC Inhibitor in Murine Cardiac AllograftsCirculation, 2004
- Inhibition of δ-Protein Kinase C Protects Against Reperfusion Injury of the Ischemic Heart In VivoCirculation, 2003
- Transforming growth factor β and diastolic left ventricular dysfunction after heart transplantation: echocardiographic and histologic evidenceThe Journal of Heart and Lung Transplantation, 2003
- Peptide modulators of protein–protein interactions in intracellular signalingNature Biotechnology, 1998
- A Selective ε-Protein Kinase C Antagonist Inhibits Protection of Cardiac Myocytes from Hypoxia-induced Cell DeathJournal of Biological Chemistry, 1997
- Inhibition of protein kinase C function by injection of intracellular receptors for the enzymeBiochemical and Biophysical Research Communications, 1992
- PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICETransplantation, 1973